Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Smith & Nephew plc (GB:SN)
LSE:SN
Holding GB:SN?
Track your performance easily
SN Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range911.00p - 1,245.26p
Previous Close997p
Volume219.40K
Average Volume (3M)2.94M
Market Cap
£8.69B
Enterprise Value10.91B
Total Cash (Recent Filing)$302.00M
Total Debt (Recent Filing)$3.08B
Price to Earnings (P/E)35.9
Beta0.96
Next Earnings
Feb 25, 2025EPS Estimate
£0.37Last Dividend Ex-Date
Oct 03, 2024Dividend Yield2.97%
Share Statistics
EPS (TTM)0.28
Shares Outstanding874,374,111
10 Day Avg. Volume2,827,668
30 Day Avg. Volume2,940,609
Standard Deviation0.07
R-Squared0.27
Alpha-0.00779
Financial Highlights & Ratios
Price to Book (P/B)163.83
Price to Sales (P/S)2.05
Price to Cash Flow (P/CF)24.30
P/FCF Ratio42.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.86
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
1,263.18pPrice Target Upside26.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Smith & Nephew News
Bulls Say, Bears Say
Bulls Say
Company StrategyThe increase in robotic adoption for joint replacement is a key growth driver.
Earnings And ValuationValuation looks attractive on earnings growth and returns compared to peers.
Operational EfficiencyNew savings opportunities are boosting confidence in future margins.
Bears Say
Financial PerformanceSmith & Nephew released a disappointing Q3 trading report, with growth in the US Orthopaedics business still lagging peers and headwinds in China leading to guidance downgrades.
Market PerformanceThe slow pace of recovery in the US Hip and Knee businesses remains well below the market growth rate, indicating doubts that the company will narrow the gap with peers in the next 12 months.
Market ShareThe US Large Joint segment remains a core hurdle, with the company still losing market share.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.10% Insiders
11.63% Mutual Funds
<0.01% Other Institutional Investors
79.48% Public Companies and
Individual Investors
SN FAQ
What was Smith & Nephew plc’s price range in the past 12 months?
Smith & Nephew plc lowest share price was 911.00p and its highest was 1245.26p in the past 12 months.
What is Smith & Nephew plc’s market cap?
Currently, no data Available
When is Smith & Nephew plc’s upcoming earnings report date?
Smith & Nephew plc’s upcoming earnings report date is Feb 25, 2025 which is in 65 days.
How were Smith & Nephew plc’s earnings last quarter?
Smith & Nephew plc released its earnings results on Aug 01, 2024. The company reported 0.301p earnings per share for the quarter, missing the consensus estimate of 0.313p by -0.012p.
Is Smith & Nephew plc overvalued?
According to Wall Street analysts Smith & Nephew plc’s price is currently Undervalued.
Does Smith & Nephew plc pay dividends?
Smith & Nephew plc pays a Semiannually dividend of 11.256p which represents an annual dividend yield of 2.97%. See more information on Smith & Nephew plc dividends here
What is Smith & Nephew plc’s EPS estimate?
Smith & Nephew plc’s EPS estimate is £0.37.
How many shares outstanding does Smith & Nephew plc have?
Smith & Nephew plc has 874,375,240 shares outstanding.
What happened to Smith & Nephew plc’s price movement after its last earnings report?
Smith & Nephew plc reported an EPS of 0.301p in its last earnings report, missing expectations of 0.313p. Following the earnings report the stock price went up 6.768%.
Which hedge fund is a major shareholder of Smith & Nephew plc?
Currently, no hedge funds are holding shares in GB:SN
---
Smith & Nephew Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
1,263.18p (26.50% Upside)
1,263.18p (26.50% Upside)
Insider Transactions
Bought Shares
Worth £50.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.31%
12-Months-Change
Fundamentals
Return on Equity
5.87%
Trailing 12-Months
Asset Growth
7.70%
Trailing 12-Months
Company Description
Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
---
SN Stock 12 Month Forecast
Average Price Target
1,263.18p
▲(26.50% Upside)
Technical Analysis
Advanced Medical Solutions
―
GlaxoSmithKline
―
Hikma Pharmaceuticals
―
PureTech Health
―
Best Analysts Covering SN
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+5.35%
reiterated a buy rating 2 months ago
Copying David Adlington's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +5.35% per trade.
---